GSK

China bans GSK from drug procurement activities through April 2024
Endpoints
Mon, 10/31/22 - 10:17 am
China
GSK
GSK dumps major pipeline prospect otilimab on lackluster phase 3 data in rheumatoid arthritis
Fierce Biotech
Thu, 10/27/22 - 10:48 am
GSK
otilimab
rheumatoid arthritis
As GSK gears up for high-stakes daprodustat panel review, FDA flags some safety concerns
Fierce Pharma
Wed, 10/26/22 - 10:26 am
GSK
anemia
daprodustat
FDA
GSK shuffles execs and streamlines businesses as vaccines chief Connor heads for the exit
Fierce Pharma
Tue, 10/25/22 - 11:11 pm
GSK
vaccines
Emma Walmsley
GSK axes Lyell cell therapy, passes programs to Adaptimmune
Fierce Biotech
Tue, 10/25/22 - 11:04 am
GSK
Lyell
cell therapy
Adaptimmune Therapeutics
GSK's ViiV gives early look at HIV broadly neutralizing antibody's power, eyes long-acting combo trial
Fierce Biotech
Tue, 10/25/22 - 10:58 am
GSK
ViiV
bNab
N6LS
HIV
GSK’s Shingrix showed to offer ten years of shingles protection in study
Clinical Trials Arena
Thu, 10/20/22 - 10:38 am
GSK
vaccines
shingles
Shingrix
clinical trials
GSK decides time is right to pay Tempus $70M to expand access to patient data library
Fierce Biotech
Tue, 10/18/22 - 10:58 am
GSK
Tempus
drug development
clinical trials
artificial intelligence
FDA approves single-vial version of GSK's Menveo vaccine, ending need for reconstitution
Fierce Pharma
Tue, 10/18/22 - 10:55 am
GSK
FDA
vaccines
Menveo
meningococcal disease
Novartis, GSK and Sanofi Scale Back on Operations and Labor Forces Overseas - Updated
BioSpace
Mon, 10/17/22 - 10:46 am
Novartis
GSK
Sanofi
layoffs
FDA Review: Phanes, Pfizer, GSK and More
BioSpace
Fri, 10/14/22 - 10:38 am
FDA
Phanes
Pfizer
GSK
Regeneron
Eagle Pharmaceuticals
Galactin Therapeutics
BridgeBio
Gilead Sciences
Covis Pharma
scPharmaceuticals
XACT Robotics
BioMind Labs
Few safe havens surface in another down quarter for biopharma
EP Vantage
Fri, 10/14/22 - 10:03 am
biopharma stocks
COVID-19
Eli Lilly
Bristol Myers Squibb
Merck
Daiichi Sankyo
Vertex Pharmaceuticals
Takeda
Neurocrine
Sarepta Therapeutics
Orion
Pfizer
GSK
Roche
Moderna Therapeutics
BeiGene
BioNTech
Novavax
CureVac
GSK hits back in high-stakes RSV vaccine game, posting phase 3 data that suggest it has edge on Pfizer
Fierce Biotech
Thu, 10/13/22 - 09:47 am
GSK
RSV
vaccines
clinical trials
Pfizer
JNJ
Moderna Therapeutics
RSVPreF3
The gloom deepens for biopharma stocks
EP Vantage
Mon, 10/10/22 - 06:54 pm
biopharma stocks
AbbVie
Alnylam
AstraZeneca
Biogen
CRISPR Therapeutics
Daiichi Sankyo
Eisai
Eli Lilly
GSK
Intellia Therapeutics
Regeneron
Roche
Sanofi
Sarepta Therapeutics
GSK's Boostrix wins maternal vaccination nod to protect babies from whooping cough
Fierce Pharma
Mon, 10/10/22 - 10:49 am
GSK
vaccines
Boostrix
pertussis
pregnancy
GSK hits go on pivotal TIM-3 lung cancer trial after phase 2 clears bar for advancement
Fierce Biotech
Wed, 10/5/22 - 10:49 am
GSK
lung cancer
clinical trials
cobolimab
non-small cell lung cancer
In 'skinny' label fight between Teva and GSK, Supreme Court asks Biden admin for help
Fierce Pharma
Tue, 10/4/22 - 11:01 am
GSK
Teva Pharmaceutical
Joe Biden
Supreme Court
skinny labels
Go or no go? GSK takes its turn with a novel anemia class
EP Vantage
Fri, 09/30/22 - 10:52 am
FDA
GSK
Amicus Therapeutics
AstraZeneca
Novartis
Supernus
JNJ
Ipsen
Y-mAbs Therapeutics
GSK Hires Julie Brown for Creating All-Female Top Team
Marketscreener
Mon, 09/26/22 - 11:00 am
GSK
Julie Brown
women
hirings
CFO
GSK plays the white knight, paying $66M to rescue Spero's oral antibiotic after FDA rejection
Fierce Biotech
Thu, 09/22/22 - 10:54 am
GSK
Spero Therapeutics
antibiotics
tebipenem

Pages